Proposed Data Collections Submitted for Public Comment and Recommendations, 75255-75256 [06-9723]

Download as PDF Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices Evaluation of Selenium in Elk in the Southeast Idaho Phosphate Resource Area Illinois Belvidere Municipal Landfill #1 Bohn Heat Transfer Facility Dixie Auto Salvage Lincoln Limited Landfill Smith-Douglass Iowa Iowa City Former Manufactured Gas Plant Site Tails A Waggin’ Pet Resort—Arsenic Soil Contamination Louisiana Bayou Sorrel—Post-Hurricane Groundwater Sampling Evaluation Combustion, Inc.—Post-Hurricane Groundwater Sampling Evaluation Devil’s Swamp Lake—A Review of Fish Data Hurricane Response Sampling Assessment for D.L. Mud, Inc. Hurricane Response Sampling Assessment for Gulf Coast Vacuum Services Hurricane Response Sampling Assessment for PAB Oil & Chemical Service, Inc. Hurricane Response Sampling Assessment for the Agriculture Street Landfill Hurricane Response Sampling Assessment for the Southern Shipbuilding Corporation Petro Processors of Louisiana, Inc.— Post-Hurricane Groundwater Sampling Evaluation Maine Contaminant Accumulation Potential in Plants and Animals Used by the Aroostook Band of Micmac Indians at the Former Loring Air Force Base Holtrachem Manufacturing Company Massachusetts Environmental Data Review for Witchcraft Heights Elementary School and Nearby Properties Former Zonolite Facility—Wemelco Way rwilkins on PROD1PC63 with NOTICES Michigan I–75/Caniff Area (Hamtramck) Lead Contamination (a/k/a ‘‘Grand Haven’’ Area (Hamtramck) Lead Contamination) Little Black Creek Sediments Little Black Creek Sediments— Floodplain Soil Sampling Results Petersburg Mercury Site 17:54 Dec 13, 2006 Jkt 211000 Texas Former Park Rapids Dump Off-Site Soils: CMC Heartland Partners Lite Yard Site St. Louis River Sediments: U.S. Steel Site—Dioxin and Polycyclic Aromatic Hydrocarbon Chemical Signatures (Fingerprints) in Sediments St. Louis River Sediments: U.S. Steel Site—Technical Review of Discrepancies in 2002 Lacer Induced Fluorescence Data, and 2003 and 2004 Analytical Data Cox Road Dump Site—Barium Health Concern Tenaha Wood Treating Tronox LLC, Texarkana Facility Washington Yerington Anaconda Mine Site (a/k/a Anaconda Mine) BSB Diversified/Hexcel Corporation— Evaluation of Ground Water Contamination DNR Triangle Gravel Pit Gilbert Elementary School—Evaluation of Soil Contamination Holmes Harbor Lincoln Elementary School—Evaluation of Soil Contamination Manson Elementary School—Evaluation of Soil Contamination Naches Valley Intermediate School— Evaluation of Soil Contamination Robertson Elementary School— Evaluation of Soil Contamination Washington Elementary School— Evaluation of Soil Contamination New Hampshire Wisconsin Bear Brook Villa Cancer Incidence: Residents of Claremont, Sullivan County, New Hampshire (Wheelabrator-Claremont Site) Badger Army Ammunition Plant— Dinitrotoluene in Private Wells Econocare Cleaners Vapor Intrusion Investigation Redi-Quik Dry Cleaners—Vapor Intrusion in a Private Residence Brewer Brothers Petroleum Bulk Plant Former Cardwell Memorial Hospital Former Zonolite Company/W.R. Grace Facility—St. Louis Sherrill Mini Mart/Health Clinic Martin County Coal Slurry Release Rubbertown Industrial Area VerDate Aug<31>2005 Minnesota Missouri Kentucky 75255 Nevada New Jersey Adrow Chemical Company Site Kiddie Kollege—Mercury Exposure Investigation Matteo & Sons (a/k/a Matteo Iron and Metal Site) New York Mariners Marsh Park—Area of Concern North Carolina Payne Road Solvents Sigmon’s Septic Tank Service— Evaluation of Surface Water Data Ohio Dated: December 8, 2006. Kenneth Rose, Acting Director, Office of Policy, Planning, and Evaluation, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. [FR Doc. E6–21263 Filed 12–13–06; 8:45 am] BILLING CODE 4163–70–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Fair Oak Park [30 Day–07–0641] Oregon Proposed Data Collections Submitted for Public Comment and Recommendations North Morrow and Northwest Umatilla Perchlorate Area Salem-Keizer School District—3M Flooring Pennsylvania Former W.R. Grace/Zonolite Co. Facility—Investigation of Nearby Play Area Waymart Spill Site Tennessee Clover Creek Workers (a/k/a Velsicol Chemical Corp.) Cypress Creek Sub-Area III Glover Site (a/k/a Tennessee Products) Skyline Drive Dump PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at 404–639–4604 or send a e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. E:\FR\FM\14DEN1.SGM 14DEN1 75256 Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices Background and Brief Description Descriptive Epidemiology of Missed or Delayed Diagnoses for Conditions Detected by Newborn Screening—(OMB No. 0920–0641)—Revision—National Center for Environmental Health (NCEH), Centers for Disease Control and Prevention (CDC). Every state in the United States and Washington, DC, has a public health program to test newborn babies for congenital metabolic and other disorders through laboratory testing of dried blood spots. These programs screen for between four and 36 different conditions including phenylketonuria (PKU) and congenital hypothroidism, with testing performed in both state laboratories and private laboratories contracted by state health departments. The screening process or system is broader than the state public health newborn screening program, which is composed only of the laboratory and follow-up personnel. Most children born with metabolic disease are identified in a timely manner and within the parameters defined by the newborn screening system of each state. These children are referred for diagnosis and treatment. However, some cases are not detected at all or the detection comes too late to prevent harm. These ‘‘missed cases’’ often result in severe morbidity such as mental retardation or death. In this project, we will continue to collect information about missed or delayed diagnoses in order to update and expand a previous epidemiological study of missed cases of two disorders published in 1986. We will assess the number of cases of each disorder missed, and the potential reasons for the miss and legal outcomes. Data will be collected by asking state public health laboratory directors, newborn screening laboratory managers, follow-up coordinators, specialists at metabolic clinics, and parent groups with an interest in newborn screening for information regarding missed cases. An estimated 135 remaining respondents will participate in our study by completing one or two short questionnaires that ask for information regarding the details of any missed or delayed cases of which they are aware. The survey will highlight procedures and actions taken by states and other participants in newborn screening systems to identify causes of missed cases and to modify policies and procedures to prevent or minimize recurrences. The information gleaned from this study may be used to help craft changes in the screening protocols that will make the process more organized and efficient and less likely to fail an affected child. Respondent burden is approximately 3 minutes for the State Form and 10 minutes for the Case Report Form. There are no costs to the respondents other than their time. The total estimated annual burden hours are 28. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden (hours) per response Total burden (hours) Respondents Form name Director, State Newborn Screening Laboratory. State Form .......................................... 25 1 3/60 1.3 Case State Case State Case Case Case 25 25 25 60 60 5 20 1 1 1 1 1 1 1 10/60 3/60 10/60 3/60 10/60 10/60 10/60 4.2 1.3 4.2 3 10 0.8 3.3 Follow-up State Coordinator ............... Metabolic Clinic Employee ................. Parent Advocate ................................. Parent ................................................. Dated: December 8, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 06–9723 Filed 12–13–06; 8:45 am] BILLING CODE 4163–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-07–05AJ] rwilkins on PROD1PC63 with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic VerDate Aug<31>2005 17:54 Dec 13, 2006 Jkt 211000 Report Form .............................. Form .......................................... Report Form .............................. Form .......................................... Report Form .............................. Report Form .............................. Report Form .............................. summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 be received within 60 days of this notice. Proposed Project National Surveillance for Severe Adverse Events Associated with Treatment of Latent Tuberculosis Infection—New—Division of Tuberculosis Elimination (DTBE), National Center for HIV, STD, and TB Prevention (NCHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description As part of the national TB elimination strategy, the American Thoracic Society and CDC have published recommendations for targeted testing for TB and treatment for latent TB infection (LTBI). However, between October 2000 and September 2004, the CDC received reports of 50 patients with severe adverse events associated with the use of the two or three-month regimen of rifampin and pyrazinamide (RZ) for the treatment of LTBI; 12 (24%) patients E:\FR\FM\14DEN1.SGM 14DEN1

Agencies

[Federal Register Volume 71, Number 240 (Thursday, December 14, 2006)]
[Notices]
[Pages 75255-75256]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9723]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-07-0641]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at 404-639-4604 or send a e-mail to 
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

[[Page 75256]]

Background and Brief Description

    Descriptive Epidemiology of Missed or Delayed Diagnoses for 
Conditions Detected by Newborn Screening--(OMB No. 0920-0641)--
Revision--National Center for Environmental Health (NCEH), Centers for 
Disease Control and Prevention (CDC). Every state in the United States 
and Washington, DC, has a public health program to test newborn babies 
for congenital metabolic and other disorders through laboratory testing 
of dried blood spots. These programs screen for between four and 36 
different conditions including phenylketonuria (PKU) and congenital 
hypothroidism, with testing performed in both state laboratories and 
private laboratories contracted by state health departments. The 
screening process or system is broader than the state public health 
newborn screening program, which is composed only of the laboratory and 
follow-up personnel. Most children born with metabolic disease are 
identified in a timely manner and within the parameters defined by the 
newborn screening system of each state. These children are referred for 
diagnosis and treatment. However, some cases are not detected at all or 
the detection comes too late to prevent harm. These ``missed cases'' 
often result in severe morbidity such as mental retardation or death.
    In this project, we will continue to collect information about 
missed or delayed diagnoses in order to update and expand a previous 
epidemiological study of missed cases of two disorders published in 
1986. We will assess the number of cases of each disorder missed, and 
the potential reasons for the miss and legal outcomes. Data will be 
collected by asking state public health laboratory directors, newborn 
screening laboratory managers, follow-up coordinators, specialists at 
metabolic clinics, and parent groups with an interest in newborn 
screening for information regarding missed cases. An estimated 135 
remaining respondents will participate in our study by completing one 
or two short questionnaires that ask for information regarding the 
details of any missed or delayed cases of which they are aware.
    The survey will highlight procedures and actions taken by states 
and other participants in newborn screening systems to identify causes 
of missed cases and to modify policies and procedures to prevent or 
minimize recurrences. The information gleaned from this study may be 
used to help craft changes in the screening protocols that will make 
the process more organized and efficient and less likely to fail an 
affected child.
    Respondent burden is approximately 3 minutes for the State Form and 
10 minutes for the Case Report Form. There are no costs to the 
respondents other than their time. The total estimated annual burden 
hours are 28.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                         Average
                                                        Number of       Number of        burden         Total
          Respondents                 Form name        respondents    responses per   (hours)  per      burden
                                                                       respondent       response       (hours)
----------------------------------------------------------------------------------------------------------------
Director, State Newborn          State Form........              25               1            3/60          1.3
 Screening Laboratory.
                                 Case Report Form..              25               1           10/60          4.2
Follow-up State Coordinator....  State Form........              25               1            3/60          1.3
                                 Case Report Form..              25               1           10/60          4.2
Metabolic Clinic Employee......  State Form........              60               1            3/60          3
                                 Case Report Form..              60               1           10/60         10
Parent Advocate................  Case Report Form..               5               1           10/60          0.8
Parent.........................  Case Report Form..              20               1           10/60          3.3
----------------------------------------------------------------------------------------------------------------


    Dated: December 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 06-9723 Filed 12-13-06; 8:45 am]
BILLING CODE 4163-18-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.